Vivanza Biosciences Ltd.

8.40 +0.05 ▲0.6%

04 March 2024, 04:01:00 PM
Volume: 75,127

Company Profile

Sector Trading Sector Icon Trading Compare with Sector peers
Industry Trading Industry Icon Trading Compare with Industry peers
Website http://www.vivanzabiosciences.com
Market Cap 34.08 Cr.
Enterprise Value(EV) 39.35 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.21 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 39.72 Trailing Twelve Months Ending 2023-12
Industry PE 67.41 Trailing Twelve Months Ending 2023-12
Book Value / Share 1.26 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.75 Calculated using Price: 8.52
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.00 Cr. 40,000,000 Shares
FaceValue 1
About Vivanza Biosciences Ltd.
The company is engaged in the business of business of Pharmaceutical Products.

Vivanza Biosciences Ltd. Delivery

Delivered Qty
Traded Qty

Vivanza Biosciences Ltd. Performance

1 Day
+0.60%
1 Week
+7.28%
1 Month
+5.79%
3 Month
-1.18%
6 Month
-36.46%
1 Year
-46.02%
2 Year
-47.50%
5 Year
+320.0%
10 Year
+278.38%

Vivanza Biosciences Ltd. Fundamental Ratios

8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -242.6 -17.54 5.66 -12.56 -6.46 2.41 10.01 15.78
Return on Capital Employed (%) -11.38 -10.82 12.73 -0.4 5.74 17.11 12.25 10.91
Return on Assets (%) -9.49 -7.99 2.37 -4.15 -1.75 0.72 2.77 3.15

Vivanza Biosciences Ltd. Balance Sheet

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 4 4 3 3 3 3 4 5
Non Curr. Liab. 0 1 1 0 3 1 2
Curr. Liab. 1 3 6 7 9 5 9 17 22
Minority Int.
Equity & Liab. 1 7 10 11 12 8 16 22 29
Non Curr. Assets 1 3 3 3 3 3 3 3 3
Curr. Assets 0 4 7 8 9 5 12 20 26
Misc. Exp. not W/O
Total Assets 1 7 10 11 12 8 16 22 29

Vivanza Biosciences Ltd. Profit and Loss

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3 6 3 10 10 10 18 32
Other Income 0 1 1 1 0 0
Total Income 4 6 3 10 10 11 18 32
Total Expenditure 0 -4 -6 -3 -10 -10 -10 -17 -30
PBIDT 0 0 1 0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0
Taxation 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 1 1
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0 0 0 0 0 1 1
Adjusted EPS 0 0 0 0 0 0 0 0 0

Vivanza Biosciences Ltd. Cash Flow

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 0 1 3 -3 2 -1
Cash Fr. Inv. 2 0
Cash Fr. Finan. 0 -1 -1 -3 2 -2 1
Net Change 0 -1 0 0 0 0 0
Cash & Cash Eqvt -2 -3 -3 -3 -3 0 0

Vivanza Biosciences Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 47.80 47.80 47.80 47.80 47.80 47.80 47.80 47.29 44.90
Public 52.20 52.20 52.20 52.20 52.20 52.20 52.20 52.71 55.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vivanza Biosciences Ltd. Announcements

Thu, 29 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hemant A Parikh
Thu, 29 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hemant A Parikh
Thu, 29 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hemant A Parikh

Vivanza Biosciences Ltd. Technical Scans

Mon, 04 Mar 2024
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Increase in 1 Month High Increase in 1 Month
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 5 Years High Increase in 5 Years

Vivanza Biosciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 378,058.57 3,316.30 -0.5%
Redington Ltd. 16,284.36 208.30 -0.5%
Honasa Consumer Ltd. 13,022.70 404.75 -3.5%
MMTC Ltd. 11,628.00 77.52 -1.8%
Lloyds Enterprises Ltd. 4,696.69 36.85 -3.2%
Entero Healthcare Solutions Ltd. 4,521.83 1,039.65 +1.0%
Optiemus Infracom Ltd. 2,686.04 312.85 +1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 107.63 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-12 13.54 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 404.75 -3.5%
MMTC Ltd. Consolidated 2023-12 87.92 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-12 36.98 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 0.00 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-12 53.78 312.85 +1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 9.80 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-12 2.25 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 19.85 404.75 -3.5%
MMTC Ltd. Consolidated 2023-12 7.91 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-12 3.10 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 2.92 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-12 6.64 312.85 +1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-03 0.45 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 404.75 -3.5%
MMTC Ltd. Consolidated 2023-03 0.14 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 0.63 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-03 0.14 312.85 +1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-03 22.66 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 404.75 -3.5%
MMTC Ltd. Consolidated 2023-03 247.70 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 0.00 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 312.85 +1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-03 22.66 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 404.75 -3.5%
MMTC Ltd. Consolidated 2023-03 247.70 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 0.00 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 312.85 +1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-03 79,376.78 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 404.75 -3.5%
MMTC Ltd. Consolidated 2023-03 3,528.18 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 3,300.21 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-03 1,173.88 312.85 +1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 3,316.30 -0.5%
Redington Ltd. Consolidated 2023-03 1,439.39 208.30 -0.5%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 404.75 -3.5%
MMTC Ltd. Consolidated 2023-03 1,562.27 77.52 -1.8%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 36.85 -3.2%
Entero Healthcare Solutions Ltd. Standalone 2023-03 -11.10 1,039.65 +1.0%
Optiemus Infracom Ltd. Consolidated 2023-03 41.88 312.85 +1.3%

Vivanza Biosciences Ltd. FAQ's

What is Vivanza Biosciences share price?

Can I buy Vivanza Biosciences shares now?

What is the Market Cap of Vivanza Biosciences?

What are the key metrics to analyse Vivanza Biosciences?

What is the 52 Week High and Low of Vivanza Biosciences?

What is the trend of Vivanza Biosciences share price?